search
Back to results

Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (TIE)

Primary Purpose

Non-Small Cell Lung Cancer

Status
Unknown status
Phase
Phase 2
Locations
Germany
Study Type
Interventional
Intervention
Erlotinib
Vinorelbine and Carboplatin
Sponsored by
LungenClinic Grosshansdorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Non-Small Cell Lung Cancer focused on measuring NSCLC, Elderly patients

Eligibility Criteria

70 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Histologically or cytological proven NSCLC, stage lll b (with pleural effusion) or stage lV.
  • Tumour is locally advanced and not suitable for surgery and radiotherapy is not indicated.
  • Neither cytostatic nor immunological pre-treatment
  • Age >70 years
  • At least one measurable lesion (RECIST criteria) that was not previously irradiated
  • ECOG Performance Status 0-1
  • Life expectancy > 3 month
  • Adequate bone marrow function: ANC > 1.5 x 109/L, Platelets > 100 x 109/L
  • Adequate liver function: Total Bilirubin < 1.5 x ULN, GOT/GPT< 3 x ULN (existent liver metastases < 5 x ULN)
  • Adequate renal function:creatinine clearance > 45 ml/min (calculated according to Cockroft-Gault)
  • Fertile men must agree to use an effective method of birth control while participating in this study
  • Signed written informed consent

Exclusion Criteria:

  • Uncontrolled metastasis in the CNS
  • Acute, heavy uncontrolled infection
  • Any other serious concomitant disease or medical condition, which could interfere with participating in this study
  • Severe hypersensitivity to Erlotinib or any other component
  • Hypersensitivity to Carboplatin and/or other platinum compounds
  • Hypersensitivity to Vinorelbin or other Vinca-alkaloids
  • Patients with a history of other active malignancy in the past 5 years (with the exception of carcinoma in situ of the cervix, non melanomatous skin cancers or local prostate carcinoma that was surgically treated successfully) are excluded.
  • Participation in another clinical trial with any investigational drug at the same time or within 30 days prior to registration
  • Psychological, familial, social or geographical situations limiting the compliance with the study requirements

Sites / Locations

  • GemeinschaftspraxisRecruiting
  • Zentralklinik Bad Berka GmbHRecruiting
  • Charité - Campus Benjamin FranklinRecruiting
  • Helios Klinikum Emil von BehringRecruiting
  • Evangelische Lungenklinik BerlinRecruiting
  • Evang. Krankenhaus BielefeldRecruiting
  • Johanniter-Krankenhaus BonnRecruiting
  • GemeinschaftspraxisRecruiting
  • Fachkrankenhaus CoswigRecruiting
  • Fachklinik DiekholzenRecruiting
  • Klinikum DonaustaufRecruiting
  • Katholisches Klinikum DuisburgRecruiting
  • Marien Hospital DüsseldorfRecruiting
  • Universitätsklinik EssenRecruiting
  • Klinikum Essen-MitteRecruiting
  • Krankenhaus Nordwest GmbHRecruiting
  • Asklepios Fachkliniken München-GautingRecruiting
  • Schwerpunktpraxis OnkologieRecruiting
  • Universitätsklinikum der Ernst-Moritz Arndt Universität GreifswaldRecruiting
  • Krankenhaus GroßhansdorfRecruiting
  • Georg-August-Universität GöttingenRecruiting
  • Allgemeines Krankenhaus HarburgRecruiting
  • Medizinische Hochschule HannoverRecruiting
  • Thoraxklinik am Universitätsklinikum HeidelbergRecruiting
  • Lungenklinik HemerRecruiting
  • Universitätsklinik des SaarlandesRecruiting
  • Klinikum der Friedrich-Schiller-UniversitätRecruiting
  • Klinikum KasselRecruiting
  • Malteser Krankenhaus St. Hildegardis KölnRecruiting
  • Klinikum Leverkusen gGmbHRecruiting
  • Klinik Löwenstein gGmbHRecruiting
  • Universitätsklinikum Schleswig-HolsteinRecruiting
  • Katholisches Klinikum MainzRecruiting
  • Klinikum der Johannes Gutenberg-Universität MainzRecruiting
  • Universitätsklinikum Mannheim gGmbHRecruiting
  • Zweckverband Kliniken im MühlenkreisRecruiting
  • Medizinische Klinik - InnenstadtRecruiting
  • Ruppiner Kliniken GmbHRecruiting
  • Johanniter-Krankenhaus im Fläming gGmbHRecruiting
  • Universitätsklinikum UlmRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

A

B

Arm Description

Outcomes

Primary Outcome Measures

Evaluation of the progression free survival rate with the first-line therapy

Secondary Outcome Measures

Duration of remission
1-year survival
Overall survival
Response rate (CR/RR)
Quality of life, improvement of symptoms (FACT-L)
Simplified Charlsons´Comorbidity Score
Safety and Tolerability

Full Information

First Posted
May 14, 2008
Last Updated
May 15, 2008
Sponsor
LungenClinic Grosshansdorf
search

1. Study Identification

Unique Protocol Identification Number
NCT00678964
Brief Title
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Acronym
TIE
Official Title
Multicentre Randomised Phase II Trial of Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients (=/> 70 Years) With Advanced Non-Small Cell Lung Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
May 2008
Overall Recruitment Status
Unknown status
Study Start Date
June 2006 (undefined)
Primary Completion Date
November 2008 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
LungenClinic Grosshansdorf

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
60% of all malignant diseases occur in patients who are 65 years or older. For these patients, aggressive treatments are often not suitable due to reduced life-expectancy, reduced general condition, comorbidities, and reduced vital functions which can lead to increased adverse effects of chemotherapy. Therefore, it is important to investigate alternative therapy options for elderly patients. Erlotinib is an orally applied medication which is associated with reasonable toxicity. This targeted agent may prove an effective and well-tolerated first-line therapy in elderly patients with advanced non small cell lung cancer. Therefore, the aim of this study is to investigate the progression-free survival of the combination of vinorelbine and carboplatin in comparison to erlotinib. Given that there will be no significant reduction of efficiency this may provide elderly patients of more than 70 years of age with an active oral substance without subjecting them to the sometimes severe adverse effect of the chemotherapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-Small Cell Lung Cancer
Keywords
NSCLC, Elderly patients

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
260 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Experimental
Arm Title
B
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Erlotinib
Other Intervention Name(s)
Tarceva
Intervention Description
Erlotinib 150 mg, p.o., once daily
Intervention Type
Drug
Intervention Name(s)
Vinorelbine and Carboplatin
Other Intervention Name(s)
Navelbine, Carboplat
Intervention Description
Vinorelbine 25 mg/m2, i.v., day 1 and 8 of every cycle (21 days) plus carboplatin AUC 5, i.v., day 1 of every cycle
Primary Outcome Measure Information:
Title
Evaluation of the progression free survival rate with the first-line therapy
Time Frame
Tumour assessment every other cycle (interval of 42 days)
Secondary Outcome Measure Information:
Title
Duration of remission
Time Frame
Tumour assessment every other cycle (interval of 42 days)
Title
1-year survival
Time Frame
1 year
Title
Overall survival
Time Frame
End of study
Title
Response rate (CR/RR)
Time Frame
Tumour assessment every other cycle (interval of 42 days)
Title
Quality of life, improvement of symptoms (FACT-L)
Time Frame
Every other cycle (interval of 42 days)
Title
Simplified Charlsons´Comorbidity Score
Time Frame
baseline
Title
Safety and Tolerability
Time Frame
continously

10. Eligibility

Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Histologically or cytological proven NSCLC, stage lll b (with pleural effusion) or stage lV. Tumour is locally advanced and not suitable for surgery and radiotherapy is not indicated. Neither cytostatic nor immunological pre-treatment Age >70 years At least one measurable lesion (RECIST criteria) that was not previously irradiated ECOG Performance Status 0-1 Life expectancy > 3 month Adequate bone marrow function: ANC > 1.5 x 109/L, Platelets > 100 x 109/L Adequate liver function: Total Bilirubin < 1.5 x ULN, GOT/GPT< 3 x ULN (existent liver metastases < 5 x ULN) Adequate renal function:creatinine clearance > 45 ml/min (calculated according to Cockroft-Gault) Fertile men must agree to use an effective method of birth control while participating in this study Signed written informed consent Exclusion Criteria: Uncontrolled metastasis in the CNS Acute, heavy uncontrolled infection Any other serious concomitant disease or medical condition, which could interfere with participating in this study Severe hypersensitivity to Erlotinib or any other component Hypersensitivity to Carboplatin and/or other platinum compounds Hypersensitivity to Vinorelbin or other Vinca-alkaloids Patients with a history of other active malignancy in the past 5 years (with the exception of carcinoma in situ of the cervix, non melanomatous skin cancers or local prostate carcinoma that was surgically treated successfully) are excluded. Participation in another clinical trial with any investigational drug at the same time or within 30 days prior to registration Psychological, familial, social or geographical situations limiting the compliance with the study requirements
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin Reck, Dr.
Organizational Affiliation
LungenClinic Grosshansdorf
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gemeinschaftspraxis
City
Augsburg
ZIP/Postal Code
86150
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Heinrich, Dr.
Phone
+41 821 344650
First Name & Middle Initial & Last Name & Degree
Heinrich, Dr.
Facility Name
Zentralklinik Bad Berka GmbH
City
Bad Berka
ZIP/Postal Code
99437
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bonnet, Dr.
Phone
+41 36458 51500
First Name & Middle Initial & Last Name & Degree
Bonnet, Dr.
Facility Name
Charité - Campus Benjamin Franklin
City
Berlin
ZIP/Postal Code
12200
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexander Schmittel, Dr.
Phone
+41 30 84453090
First Name & Middle Initial & Last Name & Degree
Alexander Schmittel, Dr.
Facility Name
Helios Klinikum Emil von Behring
City
Berlin
ZIP/Postal Code
14165
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Monika Serke, Dr.
Phone
+41 30 80022304
First Name & Middle Initial & Last Name & Degree
Monika Serke, Dr.
Facility Name
Evangelische Lungenklinik Berlin
City
Berlin
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sylke Kurz, Dr.
Phone
+41 30 94802112
First Name & Middle Initial & Last Name & Degree
Sylke Kurz, Dr.
Facility Name
Evang. Krankenhaus Bielefeld
City
Bielefeld
ZIP/Postal Code
33611
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meinolf Karthaus, Prof. Dr.
Phone
+41 521 77275504
First Name & Middle Initial & Last Name & Degree
Meinolf Karthaus, Prof. dr.
Facility Name
Johanniter-Krankenhaus Bonn
City
Bonn
ZIP/Postal Code
53113
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yon-Dschun Ko, Prof. Dr.
Phone
+41 228 5432202
First Name & Middle Initial & Last Name & Degree
Yon-Dschun Ko, Prof. Dr.
Facility Name
Gemeinschaftspraxis
City
Celle
ZIP/Postal Code
29221
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Raack, Dr.
Phone
+41 5141 9929490
First Name & Middle Initial & Last Name & Degree
Raack, Dr.
Facility Name
Fachkrankenhaus Coswig
City
Coswig
ZIP/Postal Code
01640
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gerd Höffken, Prof. Dr.
Phone
+41 3523 65-0
First Name & Middle Initial & Last Name & Degree
Gerd Höffken, Prof. Dr.
Facility Name
Fachklinik Diekholzen
City
Diekholzen
ZIP/Postal Code
31199
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wolfram Meister, Dr.
Phone
+41 5121 201383
First Name & Middle Initial & Last Name & Degree
Wolfram Meister, Dr.
Facility Name
Klinikum Donaustauf
City
Donaustauf
ZIP/Postal Code
93093
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Norbert Meidenbauer, Dr.
Phone
+41 9403 800
First Name & Middle Initial & Last Name & Degree
Norbert Meidenbauer, Dr.
Facility Name
Katholisches Klinikum Duisburg
City
Duisburg
ZIP/Postal Code
47166
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael Schroeder, Dr.
Phone
+41 203 5462482
First Name & Middle Initial & Last Name & Degree
Michael Schroeder, Dr.
Facility Name
Marien Hospital Düsseldorf
City
Düsseldorf
ZIP/Postal Code
40479
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Schütte, Prof. Dr.
Phone
+41 211 44002501
First Name & Middle Initial & Last Name & Degree
Schütte, Prof. Dr.
Facility Name
Universitätsklinik Essen
City
Essen
ZIP/Postal Code
45122
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eberhardt, Dr.
Phone
+41 201 723-2168
First Name & Middle Initial & Last Name & Degree
Eberhardt, Dr.
Facility Name
Klinikum Essen-Mitte
City
Essen
ZIP/Postal Code
45136
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Koester, Prof. Dr.
Phone
+41 201 1741251
First Name & Middle Initial & Last Name & Degree
Koester, Prof. Dr.
Facility Name
Krankenhaus Nordwest GmbH
City
Frankfurt/Main
ZIP/Postal Code
60488
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elke Jäger, Prof. Dr.
Phone
+41 69 76013340
First Name & Middle Initial & Last Name & Degree
Elke Jäger, Prof. Dr.
Facility Name
Asklepios Fachkliniken München-Gauting
City
Gauting
ZIP/Postal Code
82131
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
von Pawel, Dr.
Phone
+41 89 857912011
First Name & Middle Initial & Last Name & Degree
von Pawel, Dr.
Facility Name
Schwerpunktpraxis Onkologie
City
Goslar
ZIP/Postal Code
38642
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tessen, Dr.
Phone
+41 5321 686102
First Name & Middle Initial & Last Name & Degree
Tessen, Dr.
Facility Name
Universitätsklinikum der Ernst-Moritz Arndt Universität Greifswald
City
Greifswald
ZIP/Postal Code
17475
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ralf Ewert, Prof. Dr.
Phone
+41 3834 866776
First Name & Middle Initial & Last Name & Degree
Ralf Ewert, Prof. Dr.
Facility Name
Krankenhaus Großhansdorf
City
Großhansdorf
ZIP/Postal Code
22927
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Martin Reck, Dr.
Phone
+41 4102 601188
First Name & Middle Initial & Last Name & Degree
Martin Reck, Dr.
Facility Name
Georg-August-Universität Göttingen
City
Göttingen
ZIP/Postal Code
37075
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Schüttrumpf, Dr.
Phone
+41 551 398538
First Name & Middle Initial & Last Name & Degree
Schüttrumpf, Dr.
Facility Name
Allgemeines Krankenhaus Harburg
City
Hamburg
ZIP/Postal Code
21075
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kaukel, Prof. Dr.
Phone
+41 40 1818860
First Name & Middle Initial & Last Name & Degree
Kaukel, Prof. Dr.
Facility Name
Medizinische Hochschule Hannover
City
Hannover
ZIP/Postal Code
30625
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicolas Dickgreber, Dr.
Phone
+41 511 5323934
First Name & Middle Initial & Last Name & Degree
Nicolas Dickgreber, Dr.
Facility Name
Thoraxklinik am Universitätsklinikum Heidelberg
City
Heidelberg
ZIP/Postal Code
69126
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael Thomas, Prof. Dr.
Phone
+41 6221 3961300
First Name & Middle Initial & Last Name & Degree
Michael Thomas, Prof. Dr.
Facility Name
Lungenklinik Hemer
City
Hemer
ZIP/Postal Code
58675
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lutz Freitag, Dr.
Phone
+41 2372 9082201
First Name & Middle Initial & Last Name & Degree
Lutz Freitag, Dr.
Facility Name
Universitätsklinik des Saarlandes
City
Homburg/Saar
ZIP/Postal Code
66421
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andreas Göschel, Dr.
Phone
+41 8641 1623614
First Name & Middle Initial & Last Name & Degree
Andreas Göschel, Dr.
Facility Name
Klinikum der Friedrich-Schiller-Universität
City
Jena
ZIP/Postal Code
07740
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Angelika Reißig, Dr.
Phone
+41 3641 9329131
First Name & Middle Initial & Last Name & Degree
Angelika Reißig, Dr.
Facility Name
Klinikum Kassel
City
Kassel
ZIP/Postal Code
34125
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Martin Wolf, Prof. Dr.
Phone
+41 561 9803045
First Name & Middle Initial & Last Name & Degree
Martin Wolf, Prof. Dr.
Facility Name
Malteser Krankenhaus St. Hildegardis Köln
City
Köln
ZIP/Postal Code
50931
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael von Eiff, Prof. Dr.
Phone
+41 221 4003231
First Name & Middle Initial & Last Name & Degree
Michael von Eiff, Prof. Dr.
Facility Name
Klinikum Leverkusen gGmbH
City
Leverkusen
ZIP/Postal Code
51375
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Niederle, Prof. Dr.
Phone
+41 214 132672
First Name & Middle Initial & Last Name & Degree
Niederle, Prof. Dr.
Facility Name
Klinik Löwenstein gGmbH
City
Loewenstein
ZIP/Postal Code
74245
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fischer, Dr.
Phone
+41 7130 15-0
First Name & Middle Initial & Last Name & Degree
Fischer, Dr.
Facility Name
Universitätsklinikum Schleswig-Holstein
City
Lübeck
ZIP/Postal Code
23538
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dalhoff, Prof. Dr.
Phone
+41 451 5002375
First Name & Middle Initial & Last Name & Degree
Dalhoff, Prof. Dr.
Facility Name
Katholisches Klinikum Mainz
City
Mainz
ZIP/Postal Code
55131
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kortsik, Prof. Dr.
Phone
+41 6131 147412
First Name & Middle Initial & Last Name & Degree
Kortsik, Prof. Dr.
Facility Name
Klinikum der Johannes Gutenberg-Universität Mainz
City
Mainz
ZIP/Postal Code
55131
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fischer, Dr.
Phone
+41 6131 177135
First Name & Middle Initial & Last Name & Degree
Fischer, Dr.
Facility Name
Universitätsklinikum Mannheim gGmbH
City
Mannheim
ZIP/Postal Code
68167
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dieter Buchheidt, Dr.
Phone
+41 621 3834110
First Name & Middle Initial & Last Name & Degree
Dieter Buchheidt, Dr.
Facility Name
Zweckverband Kliniken im Mühlenkreis
City
Minden
ZIP/Postal Code
32423
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bodenstein, Prof. Dr.
Phone
+41 571 801-4810
First Name & Middle Initial & Last Name & Degree
Bodenstein, Prof. Dr.
Facility Name
Medizinische Klinik - Innenstadt
City
München
ZIP/Postal Code
80336
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Huber, Prof. Dr.
Phone
+41 89 51602590
First Name & Middle Initial & Last Name & Degree
Huber, Prof. Dr.
Facility Name
Ruppiner Kliniken GmbH
City
Neuruppin
ZIP/Postal Code
16816
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Deppermann, Dr.
Phone
+49 3391 393112
First Name & Middle Initial & Last Name & Degree
Deppermann, Dr.
Facility Name
Johanniter-Krankenhaus im Fläming gGmbH
City
Treuenbrietzen
ZIP/Postal Code
14929
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steffi Mai, Dr.
Phone
+41 33748 82441
First Name & Middle Initial & Last Name & Degree
Steffi Mai, Dr.
Facility Name
Universitätsklinikum Ulm
City
Ulm
ZIP/Postal Code
89081
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stefan Schumann, Dr.
Phone
+41 731 50024453
First Name & Middle Initial & Last Name & Degree
Stefan Krüger, Dr.

12. IPD Sharing Statement

Learn more about this trial

Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

We'll reach out to this number within 24 hrs